Jubilant Life sciences

Revenue was posted at Rs 763 crore and consolidated revenue was at Rs 5,826 crore

Brand India Pharma was strongly represented by Indian pharma companies at various platforms

Recognised under the ‘Chemicals and Pharmaceutical category’ for consistent efforts in quality enhancement

Jubilant Life Sciences has appointed Gurpartap Singh Sachdeva has been appointed as the Chief Executive Officer, Jubilant Pharma,…

Jubilant Life Sciences, Lupin and Aurobindo Pharma have received final approval from the US Food and Drug Administration (US FDA)…

Mycophenolate Mofetil is an immunosuppressant to help prevent organ rejection in transplants and Rizatriptan is used for the…